(Q53247935)

12 May 2018

title

Expression of HuR, COX-2, and survivin in lung cancers; cytoplasmic HuR stabilizes cyclooxygenase-2 in squamous cell carcinomas. (English)

1 reference

12 May 2018

author name string

Gou Young Kim

series ordinal

1

1 reference

12 May 2018

Sung-Jig Lim

series ordinal

2

1 reference

12 May 2018

Youn Wha Kim

series ordinal

3

1 reference

12 May 2018

publication date

13 May 2011

1 reference

12 May 2018

published in

Modern Pathology

1 reference

12 May 2018

volume

24

1 reference

12 May 2018

issue

10

1 reference

12 May 2018

page(s)

1336-1347

1 reference

12 May 2018

https://scigraph.springernature.com/pub.10.1038/modpathol.2011.90

exact match

0 references

cites work

HuR and mRNA stability

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.90

Delineation of mRNA export pathways by the use of cell-permeable peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.90

Prostaglandin synthase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.90

COX-2 is expressed in human pulmonary, colonic, and mammary tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.90

Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.90

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.90

Regulating access to the genome: nucleocytoplasmic transport throughout the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.90

Subcellular localization and nucleocytoplasmic transport of the chromosomal passenger proteins before nuclear envelope breakdown

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.90

The Survivin-Crm1 interaction is essential for chromosomal passenger complex localization and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.90

Control of apoptosis and mitotic spindle checkpoint by survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.90

The Survivin saga goes in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.90

Targeting survivin in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.90

Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.90

Survivin gene expression in early-stage non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.90

Nuclear survivin as a biomarker for non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.90

Prognostic significance of anti-apoptosis proteins survivin and bcl-2 in non-small cell lung carcinomas: a clinicopathologic study of 102 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.90

Correlation between survivin expression and prognosis in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.90

Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.90

A new cyclooxygenase-2 inhibitor, (1E,4E)-1,5-bis(2-bromophenyl)penta-1,4-dien-3-one (GL63) suppresses cyclooxygenase-2 gene expression in human lung epithelial cancer cells: coupled mRNA stabilization and posttranscriptional inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.90

The RNA-binding protein HuR regulates the expression of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.90

Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.90

Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.90

Expression of the ELAV-like protein HuR in human colon cancer: association with tumor stage and cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.90

Cyclooxygenase-2: a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.90

Nuclear or cytoplasmic expression of survivin: what is the significance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.90

Nuclear export is essential for the tumor-promoting activity of survivin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.90

Dynamic intracellular survivin in oral squamous cell carcinoma: underlying molecular mechanism and potential as an early prognostic marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.90

Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.90

7 January 2021

COX-2-dependent stabilization of survivin in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.90

7 January 2021

CRM1-mediated nuclear export determines the cytoplasmic localization of the antiapoptotic protein Survivin

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.90

7 January 2021

Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.90

7 January 2021

Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.90

7 January 2021

Survivin expression in non-small-cell lung carcinomas: correlation with apoptosis and other apoptosis-related proteins, clinicopathologic prognostic factors and prognosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.90

7 January 2021

[Subcellular localization of survivin in non-small cell lung cancer]

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.90

7 January 2021

Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.90

7 January 2021

Immunohistochemical detection of nuclear survivin in NSCLC: a comparison of commercial antibodies

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.90

7 January 2021

10.1038/MODPATHOL.2011.90

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018